11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Meet Veristat at CMO Summit 360° 2025
Discover what makes Veristat a distinguished name in the life sciences industry. Veristat is a scientifically driven global clinical research organization (CRO) and consultancy that integrates full-service clinical trial execution, regulatory consulting, and strategic planning to accelerate the development, approval, and commercialization of groundbreaking therapies worldwide.
Join us at CMO Summit 360° 2025, the largest gathering of biotech Chief Medical Officers across indications, modalities, company stages, professional experience levels, and geographic locations. We collaborate closely with CMOs to ensure scientific integrity and quality throughout the duration of your trial.
Veristat attendees:
- John P. Balser, PhD - Founder, President, and Chief Statistical Officer
Barbara Balser, VMD - Founder, Executive Vice President, and Chief Scientific Officer
Erin Gaffney - Senior Business Development Director
Conference details:
Date: April 7-8, 2025
Location: Boston Park Plaza
Our experienced team looks forward to discussing how Veristat can support your clinical research and regulatory needs in the evolving biotech landscape.
Schedule a meeting:
Fill out the form to schedule a meeting with Veristat team to learn how we can help you accelerate your clinical trials, regulatory submissions, and market access strategies.
Learn more about the conference
Schedule A Meeting
Meet with us at CMO Summit 360 º 2025 by filling out the form below.
8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...